APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioconjugation

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bioconjugation Industry Growth and Trends Forecast to 2032

26 December 2025119 pages

Choose your research edition.

Industry ResearchBioconjugation Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioconjugation Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Bioconjugation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioconjugation Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioconjugation Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Bioconjugation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bioconjugation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bioconjugation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioconjugation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bioconjugation include WuXi Biologics, Thermo Fisher Scientific, Merck, Roche, Lonza, AbbVie, Sartorius, Promega and Piramal Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bioconjugation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bioconjugation market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bioconjugation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bioconjugation.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bioconjugation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bioconjugation Market by Company

WuXi Biologics

Thermo Fisher Scientific

Merck

Roche

Lonza

AbbVie

Sartorius

Promega

Piramal Pharma

Genscript Biotech

Danaher

Charles River Laboratories

Catalent

Bio-Rad Laboratories

BD

Agilent

Bioconjugation Segment by Type

Chemical Conjugation

Click Chemistry

Enzyme-mediated Conjugatio

Others

Bioconjugation Segment by Application

Pharmaceutical

Hosptial

Research Institutes

Others

Bioconjugation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioconjugation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bioconjugation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bioconjugation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Chemical Conjugation Table 2. Major Company of Click Chemistry Table 3. Major Company of Enzyme-mediated Conjugatio Table 4. Major Company of Others Table 5. Global Bioconjugation Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Bioconjugation Sales by Type (2021-2026) & (Units) Table 7. Global Bioconjugation Sales Market Share in Volume by Type (2021-2026) Table 8. Global Bioconjugation Sales by Type (2021-2026) & (US$ Million) Table 9. Global Bioconjugation Sales Market Share in Value by Type (2021-2026) Table 10. Global Bioconjugation Price by Type (2021-2026) & (US$/Unit) Table 11. Global Bioconjugation Sales by Type (2027-2032) & (Units) Table 12. Global Bioconjugation Sales Market Share in Volume by Type (2027-2032) Table 13. Global Bioconjugation Sales by Type (2027-2032) & (US$ Million) Table 14. Global Bioconjugation Sales Market Share in Value by Type (2027-2032) Table 15. Global Bioconjugation Price by Type (2027-2032) & (US$/Unit) Table 16. North America Bioconjugation Sales by Type (2021-2026) & (Units) Table 17. North America Bioconjugation Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Bioconjugation Sales by Type (2021-2026) & (Units) Table 19. Europe Bioconjugation Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Bioconjugation Sales by Type (2021-2026) & (Units) Table 21. Asia-Pacific Bioconjugation Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Bioconjugation Sales by Type (2021-2026) & (Units) Table 23. Latin America Bioconjugation Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Bioconjugation Sales by Type (2021-2026) & (Units) Table 25. Middle East and Africa Bioconjugation Sales by Type (2021-2026) & (US$ Million) Table 26. Bioconjugation Industry Trends Table 27. Bioconjugation Industry Drivers Table 28. Bioconjugation Industry Opportunities and Challenges Table 29. Bioconjugation Industry Restraints Table 30. Global Bioconjugation Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Bioconjugation Revenue Market Share by Company (2021-2026) Table 32. Global Bioconjugation Sales by Company (2021-2026) & (Units) Table 33. Global Bioconjugation Sales Share by Company (2021-2026) Table 34. Global Bioconjugation Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Bioconjugation Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Bioconjugation Major Company Production Sites and Headquarters Table 37. Global Bioconjugation Company, Product Type & Application Table 38. Global Bioconjugation Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Bioconjugation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Bioconjugation Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Bioconjugation Sales by Region (2021-2026) & (Units) Table 43. Global Bioconjugation Sales Market Share in Volume by Region (2021-2026) Table 44. Global Bioconjugation Sales by Region (2021-2026) & (US$ Million) Table 45. Global Bioconjugation Sales Market Share in Value by Region (2021-2026) Table 46. Global Bioconjugation Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Bioconjugation Sales by Region (2027-2032) & (Units) Table 48. Global Bioconjugation Sales Market Share in Volume by Region (2027-2032) Table 49. Global Bioconjugation Sales by Region (2027-2032) & (US$ Million) Table 50. Global Bioconjugation Sales Market Share in Value by Region (2027-2032) Table 51. Global Bioconjugation Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Bioconjugation Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Bioconjugation Sales by Application (2021-2026) & (Units) Table 54. Global Bioconjugation Sales Market Share in Volume by Application (2021-2026) Table 55. Global Bioconjugation Sales by Application (2021-2026) & (US$ Million) Table 56. Global Bioconjugation Sales Market Share in Value by Application (2021-2026) Table 57. Global Bioconjugation Price by Application (2021-2026) & (US$/Unit) Table 58. Global Bioconjugation Sales by Application (2027-2032) & (Units) Table 59. Global Bioconjugation Sales Market Share in Volume by Application (2027-2032) Table 60. Global Bioconjugation Sales by Application (2027-2032) & (US$ Million) Table 61. Global Bioconjugation Sales Market Share in Value by Application (2027-2032) Table 62. Global Bioconjugation Price by Application (2027-2032) & (US$/Unit) Table 63. North America Bioconjugation Sales by Application (2021-2026) & (Units) Table 64. North America Bioconjugation Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Bioconjugation Sales by Application (2021-2026) & (Units) Table 66. Europe Bioconjugation Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Bioconjugation Sales by Application (2021-2026) & (Units) Table 68. Asia-Pacific Bioconjugation Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Bioconjugation Sales by Application (2021-2026) & (Units) Table 70. Latin America Bioconjugation Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Bioconjugation Sales by Application (2021-2026) & (Units) Table 72. Middle East and Africa Bioconjugation Sales by Application (2021-2026) & (US$ Million) Table 73. WuXi Biologics Company Information Table 74. WuXi Biologics Business Overview Table 75. WuXi Biologics Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. WuXi Biologics Bioconjugation Product Portfolio Table 77. WuXi Biologics Recent Development Table 78. Thermo Fisher Scientific Company Information Table 79. Thermo Fisher Scientific Business Overview Table 80. Thermo Fisher Scientific Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Thermo Fisher Scientific Bioconjugation Product Portfolio Table 82. Thermo Fisher Scientific Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Bioconjugation Product Portfolio Table 87. Merck Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Roche Bioconjugation Product Portfolio Table 92. Roche Recent Development Table 93. Lonza Company Information Table 94. Lonza Business Overview Table 95. Lonza Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lonza Bioconjugation Product Portfolio Table 97. Lonza Recent Development Table 98. AbbVie Company Information Table 99. AbbVie Business Overview Table 100. AbbVie Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. AbbVie Bioconjugation Product Portfolio Table 102. AbbVie Recent Development Table 103. Sartorius Company Information Table 104. Sartorius Business Overview Table 105. Sartorius Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Sartorius Bioconjugation Product Portfolio Table 107. Sartorius Recent Development Table 108. Promega Company Information Table 109. Promega Business Overview Table 110. Promega Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Promega Bioconjugation Product Portfolio Table 112. Promega Recent Development Table 113. Piramal Pharma Company Information Table 114. Piramal Pharma Business Overview Table 115. Piramal Pharma Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Piramal Pharma Bioconjugation Product Portfolio Table 117. Piramal Pharma Recent Development Table 118. Genscript Biotech Company Information Table 119. Genscript Biotech Business Overview Table 120. Genscript Biotech Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Genscript Biotech Bioconjugation Product Portfolio Table 122. Genscript Biotech Recent Development Table 123. Danaher Company Information Table 124. Danaher Business Overview Table 125. Danaher Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Danaher Bioconjugation Product Portfolio Table 127. Danaher Recent Development Table 128. Charles River Laboratories Company Information Table 129. Charles River Laboratories Business Overview Table 130. Charles River Laboratories Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Charles River Laboratories Bioconjugation Product Portfolio Table 132. Charles River Laboratories Recent Development Table 133. Catalent Company Information Table 134. Catalent Business Overview Table 135. Catalent Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Catalent Bioconjugation Product Portfolio Table 137. Catalent Recent Development Table 138. Bio-Rad Laboratories Company Information Table 139. Bio-Rad Laboratories Business Overview Table 140. Bio-Rad Laboratories Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Bio-Rad Laboratories Bioconjugation Product Portfolio Table 142. Bio-Rad Laboratories Recent Development Table 143. BD Company Information Table 144. BD Business Overview Table 145. BD Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. BD Bioconjugation Product Portfolio Table 147. BD Recent Development Table 148. Agilent Company Information Table 149. Agilent Business Overview Table 150. Agilent Bioconjugation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Agilent Bioconjugation Product Portfolio Table 152. Agilent Recent Development Table 153. North America Bioconjugation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 154. North America Bioconjugation Sales by Country (2021-2026) & (Units) Table 155. North America Bioconjugation Sales Market Share by Country (2021-2026) Table 156. North America Bioconjugation Sales Forecast by Country (2027-2032) & (Units) Table 157. North America Bioconjugation Sales Market Share Forecast by Country (2027-2032) Table 158. North America Bioconjugation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Bioconjugation Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Bioconjugation Market Share by Country (2021-2026) Table 161. North America Bioconjugation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Bioconjugation Market Share Forecast by Country (2027-2032) Table 163. Europe Bioconjugation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 164. Europe Bioconjugation Sales by Country (2021-2026) & (Units) Table 165. Europe Bioconjugation Sales Market Share by Country (2021-2026) Table 166. Europe Bioconjugation Sales Forecast by Country (2027-2032) & (Units) Table 167. Europe Bioconjugation Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Bioconjugation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Bioconjugation Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Bioconjugation Market Share by Country (2021-2026) Table 171. Europe Bioconjugation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Bioconjugation Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Bioconjugation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Bioconjugation Sales by Country (2021-2026) & (Units) Table 175. Asia-Pacific Bioconjugation Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Bioconjugation Sales Forecast by Country (2027-2032) & (Units) Table 177. Asia-Pacific Bioconjugation Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Bioconjugation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Bioconjugation Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Bioconjugation Market Share by Country (2021-2026) Table 181. Asia-Pacific Bioconjugation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Bioconjugation Market Share Forecast by Country (2027-2032) Table 183. Latin America Bioconjugation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 184. Latin America Bioconjugation Sales by Country (2021-2026) & (Units) Table 185. Latin America Bioconjugation Sales Market Share by Country (2021-2026) Table 186. Latin America Bioconjugation Sales Forecast by Country (2027-2032) & (Units) Table 187. Latin America Bioconjugation Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Bioconjugation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Bioconjugation Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Bioconjugation Market Share by Country (2021-2026) Table 191. Latin America Bioconjugation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Bioconjugation Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Bioconjugation Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Bioconjugation Sales by Country (2021-2026) & (Units) Table 195. Middle East and Africa Bioconjugation Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Bioconjugation Sales Forecast by Country (2027-2032) & (Units) Table 197. Middle East and Africa Bioconjugation Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Bioconjugation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Bioconjugation Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Bioconjugation Market Share by Country (2021-2026) Table 201. Middle East and Africa Bioconjugation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Bioconjugation Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Bioconjugation Distributors List Table 206. Bioconjugation Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Bioconjugation Image Figure 2. Global Bioconjugation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioconjugation Market Size (2021-2032) & (US$ Million) Figure 4. Global Bioconjugation Sales (2021-2032) & (Units) Figure 5. Chemical Conjugation Image Figure 6. Global Chemical Conjugation Sales YoY Growth (2021-2032) & (Units) Figure 7. Click Chemistry Image Figure 8. Global Click Chemistry Sales YoY Growth (2021-2032) & (Units) Figure 9. Enzyme-mediated Conjugatio Image Figure 10. Global Enzyme-mediated Conjugatio Sales YoY Growth (2021-2032) & (Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 13. Global Bioconjugation Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Bioconjugation Market Share by Type 2025 VS 2032 Figure 15. North America Bioconjugation Sales Market Share in Volume by Type in 2025 Figure 16. North America Bioconjugation Sales Market Share in Value by Type in 2025 Figure 17. Europe Bioconjugation Sales Market Share in Volume by Type in 2025 Figure 18. Europe Bioconjugation Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Bioconjugation Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Bioconjugation Sales Market Share in Value by Type in 2025 Figure 21. Latin America Bioconjugation Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Bioconjugation Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Bioconjugation Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Bioconjugation Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Bioconjugation Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pharmaceutical Image Figure 28. Global Pharmaceutical Sales YoY Growth (2021-2032) & (Units) Figure 29. Hosptial Image Figure 30. Global Hosptial Sales YoY Growth (2021-2032) & (Units) Figure 31. Research Institutes Image Figure 32. Global Research Institutes Sales YoY Growth (2021-2032) & (Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 35. Global Bioconjugation Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Bioconjugation Market Share by Application 2025 VS 2032 Figure 37. North America Bioconjugation Sales Market Share in Volume by Application in 2025 Figure 38. North America Bioconjugation Sales Market Share in Value by Application in 2025 Figure 39. Europe Bioconjugation Sales Market Share in Volume by Application in 2025 Figure 40. Europe Bioconjugation Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Bioconjugation Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Bioconjugation Sales Market Share in Value by Application in 2025 Figure 43. Latin America Bioconjugation Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Bioconjugation Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Bioconjugation Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Bioconjugation Sales Market Share in Value by Application in 2025 Figure 47. North America Bioconjugation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. North America Bioconjugation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Bioconjugation Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Bioconjugation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Europe Bioconjugation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Bioconjugation Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Bioconjugation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Asia-Pacific Bioconjugation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Bioconjugation Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Bioconjugation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 60. Latin America Bioconjugation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Bioconjugation Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Bioconjugation Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 64. Middle East and Africa Bioconjugation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Bioconjugation Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Bioconjugation Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Bioconjugation Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Conjugation
  • Click Chemistry
  • Enzyme-mediated Conjugatio
  • Others
Applications
  • Pharmaceutical
  • Hosptial
  • Research Institutes
  • Others
Companies covered
  • WuXi Biologics
  • Thermo Fisher Scientific
  • Merck
  • Roche
  • Lonza
  • AbbVie
  • Sartorius
  • Promega
  • Piramal Pharma
  • Genscript Biotech
  • Danaher
  • Charles River Laboratories
  • Catalent
  • Bio-Rad Laboratories
  • BD
  • Agilent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bioconjugation Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bioconjugation Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bioconjugation Market by Type
  6. 1.3.1 Chemical Conjugation
  7. 1.3.2 Click Chemistry
  8. 1.3.3 Enzyme-mediated Conjugatio
  9. 1.3.4 Others
  10. 1.4 Global Bioconjugation Market Size by Type
  11. 1.4.1 Global Bioconjugation Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Bioconjugation Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Bioconjugation Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Bioconjugation Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Bioconjugation Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Bioconjugation Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Bioconjugation Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Bioconjugation Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bioconjugation Industry Trends
  2. 2.2 Bioconjugation Industry Drivers
  3. 2.3 Bioconjugation Industry Opportunities and Challenges
  4. 2.4 Bioconjugation Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bioconjugation Revenue (2021-2026)
  2. 3.2 Global Top Players by Bioconjugation Sales (2021-2026)
  3. 3.3 Global Top Players by Bioconjugation Price (2021-2026)
  4. 3.4 Global Bioconjugation Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bioconjugation Major Company Production Sites & Headquarters
  6. 3.6 Global Bioconjugation Company, Product Type & Application
  7. 3.7 Global Bioconjugation Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bioconjugation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bioconjugation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bioconjugation Tier 1, Tier 2, and Tier 3
4 Bioconjugation Regional Status and Outlook
  1. 4.1 Global Bioconjugation Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bioconjugation Historic Market Size by Region
  3. 4.2.1 Global Bioconjugation Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bioconjugation Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bioconjugation Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bioconjugation Forecasted Market Size by Region
  7. 4.3.1 Global Bioconjugation Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bioconjugation Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bioconjugation Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bioconjugation by Application
  1. 5.1 Bioconjugation Market by Application
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Hosptial
  4. 5.1.3 Research Institutes
  5. 5.1.4 Others
  6. 5.2 Global Bioconjugation Market Size by Application
  7. 5.2.1 Global Bioconjugation Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Bioconjugation Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Bioconjugation Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Bioconjugation Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Bioconjugation Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Bioconjugation Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Bioconjugation Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Bioconjugation Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 WuXi Biologics
  2. 6.1.1 WuXi Biologics Company Information
  3. 6.1.2 WuXi Biologics Business Overview
  4. 6.1.3 WuXi Biologics Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 WuXi Biologics Bioconjugation Product Portfolio
  6. 6.1.5 WuXi Biologics Recent Developments
  7. 6.2 Thermo Fisher Scientific
  8. 6.2.1 Thermo Fisher Scientific Company Information
  9. 6.2.2 Thermo Fisher Scientific Business Overview
  10. 6.2.3 Thermo Fisher Scientific Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Thermo Fisher Scientific Bioconjugation Product Portfolio
  12. 6.2.5 Thermo Fisher Scientific Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Bioconjugation Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Bioconjugation Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Lonza
  26. 6.5.1 Lonza Company Information
  27. 6.5.2 Lonza Business Overview
  28. 6.5.3 Lonza Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lonza Bioconjugation Product Portfolio
  30. 6.5.5 Lonza Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie Bioconjugation Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 Sartorius
  38. 6.7.1 Sartorius Company Information
  39. 6.7.2 Sartorius Business Overview
  40. 6.7.3 Sartorius Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sartorius Bioconjugation Product Portfolio
  42. 6.7.5 Sartorius Recent Developments
  43. 6.8 Promega
  44. 6.8.1 Promega Company Information
  45. 6.8.2 Promega Business Overview
  46. 6.8.3 Promega Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Promega Bioconjugation Product Portfolio
  48. 6.8.5 Promega Recent Developments
  49. 6.9 Piramal Pharma
  50. 6.9.1 Piramal Pharma Company Information
  51. 6.9.2 Piramal Pharma Business Overview
  52. 6.9.3 Piramal Pharma Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Piramal Pharma Bioconjugation Product Portfolio
  54. 6.9.5 Piramal Pharma Recent Developments
  55. 6.10 Genscript Biotech
  56. 6.10.1 Genscript Biotech Company Information
  57. 6.10.2 Genscript Biotech Business Overview
  58. 6.10.3 Genscript Biotech Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Genscript Biotech Bioconjugation Product Portfolio
  60. 6.10.5 Genscript Biotech Recent Developments
  61. 6.11 Danaher
  62. 6.11.1 Danaher Company Information
  63. 6.11.2 Danaher Business Overview
  64. 6.11.3 Danaher Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Danaher Bioconjugation Product Portfolio
  66. 6.11.5 Danaher Recent Developments
  67. 6.12 Charles River Laboratories
  68. 6.12.1 Charles River Laboratories Company Information
  69. 6.12.2 Charles River Laboratories Business Overview
  70. 6.12.3 Charles River Laboratories Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Charles River Laboratories Bioconjugation Product Portfolio
  72. 6.12.5 Charles River Laboratories Recent Developments
  73. 6.13 Catalent
  74. 6.13.1 Catalent Company Information
  75. 6.13.2 Catalent Business Overview
  76. 6.13.3 Catalent Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Catalent Bioconjugation Product Portfolio
  78. 6.13.5 Catalent Recent Developments
  79. 6.14 Bio-Rad Laboratories
  80. 6.14.1 Bio-Rad Laboratories Company Information
  81. 6.14.2 Bio-Rad Laboratories Business Overview
  82. 6.14.3 Bio-Rad Laboratories Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bio-Rad Laboratories Bioconjugation Product Portfolio
  84. 6.14.5 Bio-Rad Laboratories Recent Developments
  85. 6.15 BD
  86. 6.15.1 BD Company Information
  87. 6.15.2 BD Business Overview
  88. 6.15.3 BD Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 BD Bioconjugation Product Portfolio
  90. 6.15.5 BD Recent Developments
  91. 6.16 Agilent
  92. 6.16.1 Agilent Company Information
  93. 6.16.2 Agilent Business Overview
  94. 6.16.3 Agilent Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Agilent Bioconjugation Product Portfolio
  96. 6.16.5 Agilent Recent Developments
7 North America by Country
  1. 7.1 North America Bioconjugation Sales by Country
  2. 7.1.1 North America Bioconjugation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bioconjugation Sales by Country (2021-2026)
  4. 7.1.3 North America Bioconjugation Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bioconjugation Market Size by Country
  6. 7.2.1 North America Bioconjugation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bioconjugation Market Size by Country (2021-2026)
  8. 7.2.3 North America Bioconjugation Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bioconjugation Sales by Country
  2. 8.1.1 Europe Bioconjugation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bioconjugation Sales by Country (2021-2026)
  4. 8.1.3 Europe Bioconjugation Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bioconjugation Market Size by Country
  6. 8.2.1 Europe Bioconjugation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bioconjugation Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bioconjugation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bioconjugation Sales by Country
  2. 9.1.1 Asia-Pacific Bioconjugation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bioconjugation Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bioconjugation Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bioconjugation Market Size by Country
  6. 9.2.1 Asia-Pacific Bioconjugation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bioconjugation Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bioconjugation Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bioconjugation Sales by Country
  2. 10.1.1 South America Bioconjugation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bioconjugation Sales by Country (2021-2026)
  4. 10.1.3 South America Bioconjugation Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bioconjugation Market Size by Country
  6. 10.2.1 South America Bioconjugation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bioconjugation Market Size by Country (2021-2026)
  8. 10.2.3 South America Bioconjugation Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bioconjugation Sales by Country
  2. 11.1.1 Middle East and Africa Bioconjugation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bioconjugation Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bioconjugation Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bioconjugation Market Size by Country
  6. 11.2.1 Middle East and Africa Bioconjugation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bioconjugation Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bioconjugation Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bioconjugation Value Chain Analysis
  2. 12.1.1 Bioconjugation Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bioconjugation Production Mode & Process
  7. 12.2 Bioconjugation Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bioconjugation Distributors
  10. 12.2.3 Bioconjugation Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst